PascalFr.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

La maladie de Parkinson en France (serveur d'exploration) - Exploration (Accueil)

Index « PascalFr.i » - entrée « Noradrénaline »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Nootrope < Noradrénaline < Nord  Facettes :

List of bibliographic references indexed by Noradrénaline

Number of relevant bibliographic references: 16.
Ident.Authors (with country if any)Title
001409 (2012) M. Sabbar [France, Maroc] ; C. Delaville [France] ; P. De Deurwaerdere [France] ; A. Benazzouz [France] ; N. Lakhdar-Ghazal [Maroc]LEAD INTOXICATION INDUCES NORADRENALINE DEPLETION, MOTOR NONMOTOR DISABILITIES, AND CHANGES IN THE FIRING PATTERN OF SUBTHALAMIC NUCLEUS NEURONS
001429 (2012) C. Delaville [France] ; S. Navailles [France] ; A. Benazzouz [France]EFFECTS OF NORADRENALINE AND SEROTONIN DEPLETIONS ON THE NEURONAL ACTIVITY OF GLOBUS PALLIDUS AND SUBSTANTIA NIGRA PARS RETICULATA IN EXPERIMENTAL PARKINSONISM
001C10 (2010) David Devos [France] ; L. Defebvre [France] ; R. Bordet [France]Dopaminergic and non‐dopaminergic pharmacological hypotheses for gait disorders in Parkinson’s disease
001C88 (2010) D. Devos [France] ; R. Bordet [France] ; L. Defebvre [France]Hypothèses pharmacologiques et prise en charge thérapeutique des troubles de la marche de la maladie de Parkinson : Troubles de la marche
001D36 (2010) Dawn M. Eagle [Royaume-Uni] ; Christelle Baunez [France]Is there an inhibitory-response-control system in the rat? Evidence from anatomical and pharmacological studies of behavioral inhibition
002413 (2008) David Devos [France] ; Kathy Dujardin [France] ; Isabelle Poirot [France] ; Caroline Moreau [France] ; Olivier Cottencin [France] ; Pierre Thomas [France] ; Alain Destée [France] ; Regis Bordet [France] ; Luc Defebvre [France]Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: A double‐blind, randomized, placebo‐controlled study
002461 (2008) André Galinowski [France] ; May Ghossoub [France] ; Thomas Weber [France]Les troubles anxieux dans la maladie de Parkinson
002790 (2007) Charlotte Laloux [France] ; Philippe Derambure [France] ; Jean-Marie Jacquesson [France] ; Régis Bordet [France] ; Alain Destée [France] ; Christelle Monaca [France]The effects of serotoninergic, noradrenergic, cholinergic and dopaminergic drugs on vigilance states in MPTP-treated mice
002A92 (2006) Jean-Pierre Wolf [France] ; Malika Bouhaddi [France] ; Francis Louisy [France] ; Andrei Mikehiev [France] ; Laurent Mourot [France] ; Sylvie Cappelle [France] ; Fabrice Vuillier [France] ; Pierre Andre [France] ; Lucien Rumbach [France] ; Jacques Regnard [France]Side-effects of l-dopa on venous tone in Parkinson's disease : a leg-weighing assessment
002F99 (2004) Marc R. Marien [France] ; Francis C. Colpaert [France] ; Alan C. Rosenquist [France, États-Unis]Noradrenergic mechanisms in neurodegenerative diseases: a theory
003013 (2004) M. Bouhaddi [France] ; F. Vuillier [France] ; J. O. Forkat [France] ; S. Cappelle [France] ; M. T. Henriet [France] ; L. Rumbach [France] ; J. Regnard [France]Impaired cardiovascular autonomic control in newly and long-term-treated patients with Parkinson's disease: involvement of L-dopa therapy
003261 (2003) S. Baker [France] ; E. Moyse [France] ; F. Jourdan [France] ; F. Colpaert [France] ; J. C. Martel [France] ; M. Marien [France]Effects of the α2-ADRENORECEPTOR antagonist dexefaroxan on neurogenesis in the olfactory bulb of the adult rat in vivo: Selective protection against neuronal death
004171 (1998) M.-A. Bedard [Canada] ; F. El Massioui [France] ; C. Malapani [France] ; B. Dubois [France] ; B. Pillon [France] ; B. Renault [France] ; Yves Agid [France]Attentional deficits in Parkinson's disease : Partial reversibility with naphtoxazine (SDZ NVI-085), a selective noradrenergic α1 agonist
004460 (1996-12) Un organe de contrôle inspiré de la neuromodulation pour les Réseaux à Propagation Guidée
004802 (1995) R. M. Marié [France] ; L. Barré [France] ; P. Rioux [France] ; P. Allain [France] ; B. Lechevalier [France] ; J. C. Baron [France]PET imaging of neocortical monoaminergic terminals in Parkinson's disease
005416 (1987) R. Cash ; T. Dennis ; R. L'Heureux ; R. Raisman ; F. Javoy-Agid ; B. ScattonParkinsons disease and dementia: norepinephrine and dopamine in locus ceruleus

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i -k "Noradrénaline" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i  \
                -Sk "Noradrénaline" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    PascalFr.i
   |clé=    Noradrénaline
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024